Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $5.18M in the quarter ending September 30, 2025, a decrease of -80.16%. This brings the company's revenue in the last twelve months to $43.69M, down -32.98% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.

• Revenue (ttm): $43.69M
• Revenue Growth: -32.98%
• P/S Ratio: 42.42
• Revenue / Employee: $54,611
• Employees: 800
• Market Cap: 2.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	58.84M	14.26M	32.00%
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%